Sequenom Announces Participation at the Lazard Capital Markets 8th Annual Healthcare Conference

_{//health-fitness.news-articles.net/content/2011/ .. al-markets-8th-annual-healthcare-conference.html}
^{Published in Health and Fitness on Thursday, November 10th 2011 at 4:16 GMT by Market Wire}  

Sequenom Announces Participation at the Lazard Capital Markets 8th Annual Healthcare Conference -- SAN DIEGO, Nov. 10, 2011 /PRNewswire/ --

[ ]

My news for Investors

AtLeast one of the check box should be selected You are following news about Follow the latest news about SQNM

[ ]

[ Download image ]

SAN DIEGO, Nov. 10, 2011 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: [ SQNM ]), a life sciences company providing innovative genetic analysis solutions, today announced the Company's participation at the Lazard Capital Markets 8th Annual Healthcare Conference at the Pierre Hotel in New York CityNovember 15-16, 2011.

Harry F. Hixson, Jr, Ph.D., Chairman and CEO, and Ronald M. Lindsay, Ph.D., Director and EVP of Research and Development, will present on Tuesday, November 15, 2011 beginning at 8:30 a.m. ET, to provide an overview of and update on the Company.  The presentation is expected to last approximately 30 minutes and will be web cast live through the "Investors" section of the Sequenom website at [ www.sequenom.com ].  An audio replay will be available for 30 days following the initial presentation web cast.

About Sequenom

Sequenom, Inc. (NASDAQ: [ SQNM ]) is a life sciences company committed to improving healthcare through revolutionary genetic analysis solutions. Sequenom develops innovative technology, products and diagnostic tests that target and serve discovery and clinical research, and molecular diagnostics markets. The company was founded in 1994 and is headquartered in San Diego, California. Sequenom maintains a Web site at [ http://www.sequenom.com ] to which Sequenom regularly posts copies of its press releases as well as additional information about Sequenom. Interested persons can subscribe on the Sequenom Web site to email alerts or RSS feeds that are sent automatically when Sequenom issues press releases, files its reports with the Securities and Exchange Commission or posts certain other information to the Web site.

(Logo: [ http://photos.prnewswire.com/prnh/20040415/SQNMLOGO ])

SOURCE Sequenom, Inc.

RELATED LINKS
[ http://www.sequenom.com ]